Ectopic expression of interleukin-1 receptor type II enhances cell migration through activation of the pre-interleukin 1alpha pathway.
暂无分享,去创建一个
[1] D. Roeder,et al. Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. , 1990, Science.
[2] J. Maier,et al. Endogenous interleukin 1 alpha must be transported to the nucleus to exert its activity in human endothelial cells , 1994, Molecular and cellular biology.
[3] T. Maciag,et al. Intracellular Precursor Interleukin (IL)-1α, but Not Mature IL-1α, Is Able to Regulate Human Endothelial Cell Migration in Vitro * , 1997, The Journal of Biological Chemistry.
[4] C. D’Souza-Schorey. Disassembling adherens junctions: breaking up is hard to do. , 2005, Trends in cell biology.
[5] C. Reznikoff,et al. Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. , 1987, Cancer research.
[6] K. Huebner,et al. A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. , 1991, The EMBO journal.
[7] M. Gayle,et al. Interleukin 1 signaling occurs exclusively via the type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[8] W. Birchmeier,et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells , 1991, The Journal of cell biology.
[9] G. Adler,et al. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. , 2001, Cancer research.
[10] N. Kamatani,et al. Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts , 2006, Proceedings of the National Academy of Sciences.
[11] A. H. Drummond,et al. Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor* , 1997, The Journal of Biological Chemistry.
[12] M. Gadina,et al. IL-33: A Sheep in Wolf’s Clothing? , 2007, Science's STKE.
[13] T. Gress,et al. Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer , 2007, Oncogene.
[14] G. Adler,et al. Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. , 2006, Cancer research.
[15] R. Locksley,et al. The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein , 1997 .
[16] Te-Chang Lee,et al. Distinct Gene Expression Profiles in Immortalized Human Urothelial Cells Exposed to Inorganic Arsenite and Its Methylated Trivalent Metabolites , 2005, Environmental health perspectives.
[17] S. Brown,et al. Identification of a nuclear localization sequence within the structure of the human interleukin-1 alpha precursor. , 1993, The Journal of biological chemistry.
[18] Te-Chang Lee,et al. Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[19] T. Simmet,et al. Intracellular Interleukin-1α Functionally Interacts with Histone Acetyltransferase Complexes* , 2004, Journal of Biological Chemistry.
[20] A. Mantovani,et al. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. , 1994, Immunology today.
[21] G. Berx,et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. , 2001, Molecular cell.
[22] V. Murthy,et al. Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells. , 2007, American journal of physiology. Heart and circulatory physiology.
[23] Y. Iwakura,et al. IL-1 is required for tumor invasiveness and angiogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Labow,et al. Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex (*) , 1995, The Journal of Biological Chemistry.
[25] S. Dower,et al. Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis. , 1995, Journal of immunology.
[26] T. Lee,et al. Sodium arsenite disturbs mitosis and induces chromosome loss in human fibroblasts. , 1997, Cancer research.
[27] M. Muda,et al. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. , 1995, The American journal of pathology.
[28] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[29] T. Kupper,et al. Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] W. Fiers,et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.
[31] A. Mantovani,et al. Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function , 1996, The Journal of experimental medicine.
[32] H. Sheng,et al. Prostaglandin E2 Induces the Expression of IL-1α in Colon Cancer Cells1 , 2007, The Journal of Immunology.
[33] A. Mantovani,et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.
[34] D. Boraschi,et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. , 1998, Journal of immunology.
[35] C. Dinarello,et al. The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[36] M Locati,et al. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.
[37] C. Dinarello,et al. Biologic basis for interleukin-1 in disease. , 1996, Blood.
[38] H. Carlsen,et al. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. , 2005, Arthritis and rheumatism.
[39] C. Dinarello. The many worlds of reducing interleukin-1. , 2005, Arthritis and rheumatism.
[40] T. Wright,et al. A nuclear target for interleukin-1α: Interaction with the growth suppressor necdin modulates proliferation and collagen expression , 2003, Proceedings of the National Academy of Sciences of the United States of America.